Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells
- 31 October 2012
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 66 (7), 525-529
- https://doi.org/10.1016/j.biopha.2012.02.001
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblastsJournal of Hepatology, 2011
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targetsSeminars in Cancer Biology, 2011
- Current Approach to Hepatocellular CarcinomaSurgical Clinics of North America, 2010
- Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancyJournal of Leukocyte Biology, 2010
- Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell linesBiomedicine & Pharmacotherapy, 2010
- Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progressionSeminars in Cell & Developmental Biology, 2010
- Cancer associated fibroblasts (CAFs) in tumor microenvironmentFrontiers in Bioscience-Landmark, 2010
- Hepatocellular Carcinoma – Epidemiological Trends and Risk FactorsDigestive Diseases, 2009
- Amphotericin B up‐regulates angiogenic genes in hepatocellular carcinoma cell linesEuropean Journal of Clinical Investigation, 2009
- Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breastBMC Cancer, 2008